Cat | Alive/Dead | Health status | CD4 count | Mode of CD134 interaction | No. of Envs tested | Homologous neutralisation | ||
---|---|---|---|---|---|---|---|---|
CRD2-dependent | CRD2-independent | Intermediate | ||||||
M28 | A | H | > 350 | 11 (100%) | 0 | 0 | 11 | - |
M47 | A | H | < 350 | 8 (100%) | 0 | 0 | 8 | + |
M8 | A | S | < 350 | 2 (100%) | 0 | 0 | 2 | - |
P9 | A | S | < 350 | 6 (100%) | 0 | 0 | 6 | + |
M1 | A | H | < 350 | 4 (100%) | 0 | 0 | 4 | - |
M2 | A | H | > 350 | 2 (100%) | 0 | 0 | 2 | + |
M29 | A | H | > 350 | 3 (100%) | 0 | 0 | 3 | - |
P1 | A | H | > 350 | 3 (100%) | 0 | 0 | 3 | - |
P11 | A | H | > 350 | 7 (100%) | 0 | 0 | 7 | + |
P14 | A | H | > 350 | 9 (100%) | 0 | 0 | 9 | + |
P18 | A | H | > 350 | 1 (100%) | 0 | 0 | 1 | + |
P21 | A | H | > 350 | 6 (100%) | 0 | 0 | 6 | - |
P22 | A | H | > 350 | 2 (100%) | 0 | 0 | 2 | + |
P4 | A | H | < 350 | 4 (44.4%) | 2 (22.2%) | 3 (33.3%) | 9 | + |
P5 | A | H | < 350 | 7 (87.5%) | 1 (12.5%) | 0 | 8 | + |
P6 | A | H | > 350 | 8 (100%) | 0 | 0 | 8 | - |
M15 | A | S | > 350 | 6 (66.6%) | 3 (33.3%) | 0 | 9 | + |
M20 | A | S | > 350 | 1 (100%) | 0 | 0 | 1 | - |
M32 | A | S | < 350 | 3 (75%) | 1 (25%) | 0 | 4 | - |
P13 | A | S | < 350 | 8 (88.9%) | 1 (11.1%) | 0 | 9 | + |
P17 | A | S | < 350 | 9 (100%) | 0 | 0 | 9 | - |
P7 | A | S | > 350 | 1 (50%) | 0 | 1 (50%) | 2 | + |
P8 | A | S | > 350 | 5 (100%) | 0 | 0 | 5 | - |
M25 | D | H | < 350 | 3 (50%) | 2 (33.3%) | 1 (16.7%) | 6 | + |
M46 | D | H | < 350 | 7 (87.5%) | 1 (12.5%) | 0 | 8 | + |
M49 | D | H | < 350 | 6 (100%) | 0 | 0 | 6 | + |
M14 | D | S | < 350 | 9 (90%) | 1 (10%) | 0 | 10 | + |
M26 | D | S | < 350 | 4 (66.7%) | 2 (33.3%) | 0 | 6 | + |
M30 | D | S | < 350 | 15 (94%) | 1 (6%) | 0 | 16 | + |
M33 | D | S | < 350 | 2 (11%) | 17 (89%) | 0 | 19 | - |
M41 | D | S | < 350 | 9 (75%) | 2 (17%) | 1 (8%) | 12 | - |
M5 | D | S | < 350 | 5 (55.6%) | 3 (33.3%) | 1 (11.1%) | 9 | - |
M11 | D | H | > 350 | 17 (81%) | 3 (14%) | 1 (5%) | 21 | - |
M50 | D | H | > 350 | 2 (100%) | 0 | 0 | 2 | - |
P2 | D | H | > 350 | 16 (100%) | 0 | 0 | 16 | + |
M16 | D | S | > 350 | 0 | 1 (14.3%) | 6 (85.7%) | 7 | - |
M3 | D | S | < 350 | 0 | 1 (50%) | 1 (50%) | 2 | - |
M31 | D | S | < 350 | 9 (53%) | 7 (41%) | 1 (6%) | 17 | + |
M44 | D | S | > 350 | 2 (100%) | 0 | 0 | 2 | + |